BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• GlobalData Release: MEK Inhibitors: A New Weapon in the Fight Against Melanoma

  June 21, 2012

   · 

  7 min read
• MRN Gets SMART With Its Clinical Trial Scheduling

  June 21, 2012

   · 

  1 min read
• Biotech Bay

  Eureka Genomics Lands a National Institute of Food and Agriculture Award for $100,000

  June 21, 2012

   · 

  1 min read
• Drug Development

  StemCells Inc. Initiates Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration

  June 21, 2012

   · 

  1 min read
• Drug Development

  Cleveland Biolabs Inc. and Incuron Announce Results of Studies of CBL0137 in Animal Models of Neuroblastoma

  June 21, 2012

   · 

  1 min read
• Catalyst Pharmaceutical Partners, Inc. Receives Guidance From NASDAQ Regarding Minimum Bid Price Requirement

  June 21, 2012

   · 

  1 min read
• Business

  Clarus Therapeutics Appoints Bela S. Denes, M.D. as Chief Medical Officer

  June 21, 2012

   · 

  1 min read
• Business

  Catalent Pharma Solutions and Bend Research Partner to Provide Integrated Solutions for Oral Controlled-Release Technologies

  June 21, 2012

   · 

  3 min read
• Business

  ZELTIQ(R) Aesthetics Promotes Robert Tyson to Vice President of North America Sales

  June 21, 2012

   · 

  1 min read
• Drug Development

  Chelsea Therapeutics, Inc. Release: Combined Northera™ (droxidopa) Data From Two Phase 3 Trials Confirm Symptom Improvement in Patients With Neurogenic OH

  June 21, 2012

   · 

  1 min read